BeiGene reports BRUKINSA’s efficacy edge in CLL study By Investing.com
© Reuters. BASEL, Switzerland - BeiGene (NASDAQ:), Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE (LON:): 688235), a global biotechnology firm, has ...
© Reuters. BASEL, Switzerland - BeiGene (NASDAQ:), Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE (LON:): 688235), a global biotechnology firm, has ...
Shutter2U/iStock via Getty Images Intro Relmada Therapeutics (NASDAQ:RLMD) is advancing its NMDA antagonist, REL-1017 (esmethadone), as a novel antidepressant for ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.